Evidence map›Paper›PMID 18655878›Full record

ReviewProgress in brain research2008

Endogenous modulators of synaptic transmission: cannabinoid regulation in the supraoptic nucleus.

Neil A McDonald, J Brent Kuzmiski, Nima Naderi, Yannick Schwab, Quentin J Pittman

Registry-linked trialAbstract readReview
In one paragraph

Review in Progress in brain research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03081832 (Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
8.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03081832 nacompletednot on this mapstarted 2017, after this paper: background citation

Long Term Evaluation of Infants Aged From 3 to 4 Years Old Included in the Ancient Study (Repeated Administrations of Oxytocin in Infants With Prader Willi Syndrome Aged From 0 to 6 Months) and Comparison With Not Treated and Age-matched Prader Willi Syndrome Infants (OT2SUITE)

TypeinterventionalSponsorUniversity Hospital, ToulouseRan2017 to 2018Enrolled34ConditionsPrader-Willi SyndromeArmsOxytocin, Control
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Complementary Role of Oxytocin and Vasopressin in Cardiovascular Regulation.International journal of molecular sciences · 2021
    Review
  3. Endocannabinoids and the Endocrine System in Health and Disease.Handbook of experimental pharmacology · 2015
    Review
  4. Glial control of endocannabinoid heterosynaptic modulation in hypothalamic magnocellular neuroendocrine cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2013
    Article
  5. Article
  6. Article
  7. Article
  8. Parallel regulation of a modulator-activated current via distinct dynamics underlies comodulation of motor circuit output.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2009
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Neil A McDonaldHotchkiss Brain Institute, Department of Physiology and Biophysics, Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
J Brent Kuzmiski
Nima Naderi
Yannick Schwab
Quentin J Pittman
University of Calgary · CAInstitut de génétique et de biologie moléculaire et cellulaire · FRShahid Beheshti University of Medical Sciences · IR

Funding

CIHR 15116
6 · The paper itself

Abstract

The magnocellular neurons of the hypothalamic supraoptic nucleus (SON) are a major source of both systemic and central release of the neurohypophyseal peptides, oxytocin (OXT) and arginine-vasopressin (AVP). Both OXT and AVP are released from the somatodendritic compartment of magnocellular neurons and act within the SON to modulate the electrophysiological function of these cells. Cannabinoids (CBs) affect hormonal output and the SON may represent a neural substrate through which CBs exert specific physiological and behavioural effects. Dynamic modulation of synaptic inputs is a fundamental mechanism through which neuronal output is controlled. Dendritically released OXT acts on autoreceptors to generate endocannabinoids (eCBs) which modify both excitatory and inhibitory inputs to OXT neurons through actions on presynaptic CB receptors. As such, OXT and eCBs cooperate to shape the electrophysiological properties of magnocellular OXT neurons, regulating the physiological function of this nucleus. Further study of eCB signalling in the SON, including its interaction with AVP neurons, promises to extend our understanding of the synaptic regulation of SON physiological function.

Indexed as

AnimalsArginine VasopressinBody FluidsBrainCannabinoid Receptor ModulatorsDendritic CellsHomeostasisMiceNeuronsOxytocinPituitary Gland, PosteriorReceptors, OxytocinSecond Messenger SystemsSupraoptic NucleusSynapsesSynaptic TransmissionArginine VasopressinCannabinoid Receptor ModulatorsOxytocinReceptors, Oxytocin

Identifiers

PMID18655878
PMCPMC3569497
OpenAlexW1593064890

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.